共 14 条
[1]
Svejgaard A., Platz P., Ryder L.P., HLA and disease 1982, A Survey. Immunol Rev, 70, pp. 193-218, (1983)
[2]
Takasugi M., Terasaki P.I., Hedersson B., Et al., HLA antigens in solid tumours, Cancer Res, 33, pp. 648-650, (1973)
[3]
Arce S., Lopez R., Almaguer M., Et al., HLA antigens and transitional cell carcinoma of the bladder, Mater Med Pol, 35, pp. 98-100, (1978)
[4]
Braf Z.F., Gazit E., Many M., HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder, J Urol, 122, pp. 465-466, (1979)
[5]
Terasaki P.I., Perdue S.T., Mickey M.D., HLA frequencies in cancer. A second study, Genetics of Human Cancer, pp. 321-328, (1977)
[6]
Herring D.W., Cartwright R.A., Williams D., Genetic association of transitional cell carcinoma, Br J Urol, 51, pp. 73-77, (1979)
[7]
Lytton B., O'Toole C., Tiptaft R., Et al., Histocompatibility testing in patients with carcinoma of the bladder, Cancer, 52, pp. 645-647, (1983)
[8]
Akdas A., Tokup R., Ozerkan K., Et al., Association between HLA antigens and bladder tumours, Eur Urol, 13, pp. 207-209, (1987)
[9]
Terasaki P.I., Bernoco D., Parks M.S., Et al., Microdroplet testing for HLA- A, B, C and D, Am J Clin Pathol, 69, pp. 103-106, (1978)
[10]
Green A., The epidemiological approach to studies of association between HLA and disease. II. Estimation of absolute risk, enologie and preventive fraction, Tissue Antigens, 19, pp. 245-258, (1982)